Center-Authored Papers

Filters: Author is Sato, Alicia  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Bet A, Sterrett S, Sato A, Bansal A, Goepfert PA.  2014.  Characterization of T-cell responses to cryptic epitopes in recipients of a noncodon-optimized HIV-1 vaccine.. Journal of acquired immune deficiency syndromes (1999). 65(2):142-50. Abstract
E
Gilbert PB, Sato A, Sun X, Mehrotra DV.  2009.  Efficient and robust method for comparing the immunogenicity of candidate vaccines in randomized clinical trials.. Vaccine. 27(3):396-401. Abstract
Gill DK, Huang Y, Levine GL, Sambor A, Carter DK, Sato A, Kopycinski J, Hayes P, Hahn B, Birungi J et al..  2010.  Equivalence of ELISpot assays demonstrated between major HIV network laboratories.. PloS one. 5(12):e14330. Abstract
I
Pandey JP, Namboodiri AM, Bu S, De Dieu Tapsoba J, Sato A, Dai JY.  2013.  Immunoglobulin genes and the acquisition of HIV infection in a randomized trial of recombinant adenovirus HIV vaccine.. Virology. 441(1):70-4. Abstract
M
Zak DE, Andersen-Nissen E, Peterson ER, Sato A, Hamilton KM, Borgerding J, Krishnamurty AT, Chang JT, Adams DJ, Hensley TR et al..  2012.  Merck Ad5/HIV induces broad innate immune activation that predicts CD8+ T-cell responses but is attenuated by preexisting Ad5 immunity.. Proceedings of the National Academy of Sciences of the United States of America. 109(50):E3503-12. Abstract
N
Wang Y, Whittall T, Neil S, Britton G, Mistry M, Rerks-Ngarm S, Pitisuttithum P, Kaewkungwal J, Nitayaphan S, Yu X et al..  2017.  A novel mechanism linking memory stem cells with innate immunity in protection against HIV-1 infection.. Scientific reports. 7(1):1057. Abstract
R
Ramani S, Mamani N, Villena R, Bandyopadhyay AS, Gast C, Sato A, Laucirica D, Clemens R, Estes MK, O'Ryan ML.  2016.  Rotavirus Serum IgA Immune Response in Children Receiving Rotarix Coadministered With bOPV or IPV.. The Pediatric infectious disease journal. 35(10):1137-1139. Abstract
S
Goepfert PA, Elizaga ML, Seaton K, Tomaras GD, Montefiori DC, Sato A, Hural J, De Rosa SC, Kalams SA, McElrath MJ et al..  2014.  Specificity and 6-Month Durability of Immune Responses Induced by DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-Like Particles.. The Journal of infectious diseases. Abstract
Asbach B, Kliche A, Köstler J, Perdiguero B, Esteban M, Jacobs BL, Montefiori DC, Labranche CC, Yates NL, Tomaras GD et al..  2016.  Streamlining Heterologous DNA-Prime and NYVAC/Protein-Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens.. Journal of virology. Abstract
Gray GE, Mayer KH, Elizaga ML, Bekker L-G, Allen M, Morris L, Montefiori D, De Rosa SC, Sato A, Gu N et al..  2016.  Subtype C gp140 Vaccine Boosts Immune Responses Primed by the South African AIDS Vaccine Initiative DNA-C2 and MVA-C HIV Vaccines after More than a 2-Year Gap.. Clinical and vaccine immunology : CVI. 23(6):496-506. Abstract
Zurawski G, Shen X, Zurawski S, Tomaras GD, Montefiori DC, Roederer M, Ferrari G, Lacabaratz C, Klucar P, Wang Z et al..  2017.  Superiority in Rhesus Macaques of Targeting HIV-1 Env Gp140 to CD40 Versus LOX-1 in Combination with Replication Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses.. Journal of virology. Abstract
T
Spearman P, Lally MA, Elizaga M, Montefiori D, Tomaras GD, McElrath MJ, Hural J, De Rosa SC, Sato A, Huang Y et al..  2011.  A trimeric, V2-deleted HIV-1 envelope glycoprotein vaccine elicits potent neutralizing antibodies but limited breadth of neutralization in human volunteers.. The Journal of infectious diseases. 203(8):1165-73. Abstract